Keynote Speakers, Panellists & Moderators
Main Stakeholders
 Prof. Dr. O. Golubnitschaja, Secretary-General, EPMA
Dr. V. Costigliola, President of EPMA
Healthcare in overview across the globe, Economics of Personalised Medicine
Dr. P. Bilinski, Chief of Sanitary Inspector responsible for public health in Poland
Mr. Ghulam Nabi Azad, Minister of Health and Family Welfare, India
Mr. S. S. Gandhiselvan, Minister of State for Health and Family Welfare, India
 Mr. Adoor Prakash, Minister of Health, Kerala State, India
Dr. A. Benini, Missionary of the Organisation of United Nations; National Representative of EPMA in Denmark
o Dr. R. Maksimovic, Missionary of the World Health Organisation
Prof. Dr. F. Paul, National Representative of EPMA in Germany
Dr. K. Grosios, National Representative of EPMA in UK
Prof. Dr. H. Iso, National Representative of EPMA in Japan
Dr. M. Kapalla, National Representative of EPMA in Slovak Republic
Prof. Dr. K. Richter, National Representative of EPMA in Macedonia (FYROM) and Bavaria (Germany)
Dr. D. Dimitrov, National Representative of EPMA in Bulgaria
Prof. Dr. M. Dündar, National Co-Representative of EPMA in Turkey
Prof. Dr. W. Sai Ho Chan, National Representative of EPMA in Taiwan (ROC)
Prof. Dr. I. Gozes, National Representative of EPMA in Israel
Dr. V. Costigliola, President of EPMA
Dr. K. Krapfenbauer, Vice-President of EPMA
Dr. W. Spek, Managing Director, The Netherlands
Granting Strategies in PPPM
Prof. Dr. M. Goldman, Director, Innovative Medicine Initiative, EU-Commission, Brussels
 Dr. S. Srivastava, Director, Early Detection Research Network, NIH / NCI, Washington D.C., USA
Dr. C. Longson, Director, National Institute for Health & Clinical Excellence, UK
Dr. J.-L. Sanne, Directorate for Personalised Medicine, EU-Commission, Brussels, Belgium
Dr. L. Kristiansen, Medical Sciences, European Science Foundation, Strasbourg, France
Dr. J. Greuel, Adjunct Professor of Finance & Healthcare Management IE Business School, Madrid, Spain / Managing Director, Bioscience Valuation BSV GmbH, Germany
Education in Predictive, Preventive and Personalised Medicine
Dr. J. Delgado, Head of Unit Vocational Education and Training Policy, Leonardo da Vinci Programme, EU-Commission, Brussels, Belgium
Dr. P. Butler, Editorial Director, Biomedicine, Springer
Prof. Dr. H. H. Schild, Director of Radiological Hospital, University of Bonn, Germany
Dr. M. Roelandse, Associate Editor, Biomedical Unit, Springer
Prof. Dr. O Golubnitschaja, Editor-in-Chief, The EPMA J. & Book-Series “Advances in PPPM”, EPMA / Springer
Dr. V. Costigliola, Associate Editor, The EPMA J. & Book-Series “Advances in PPPM”
Prof. Dr. M. Mozaffari, Associate Editor, The EPMA J. & Book-Series “Advances in PPPM”
Dr. S. Mandel, Associate Editor, The EPMA J. & Book-Series “Advances in PPPM”, Vice-President of EPMA
Prof. Dr. D. Desiderio, Associate Editor, The EPMA J.
 Prof. Dr. H. Iso, Associate Editor, The EPMA J.
 Prof. Dr. M. Scarpa, Associate Editor, The EPMA J.
 Prof. Dr. O. Topolcan, National Representative of EPMA in Czech Republic
Patient Needs - Challenges for Stakeholders in Predictive, Preventive and Personalised Medicine
Dr. V. Costigliola, President of EPMA
Dr. J. Mendive, National Representative of EPMA in Spain
Dr. G. Vittadini, Director of Technology Opportunities, Bracco Imaging
Prof. Dr. M. Reiser, ESR Past President, Professor and Chairman, Department of Radiology, Dean of the Medical Faculty, Ludwig Maximilians University Munich, Germany
Dr. A. Jansen, Director, DiaDexus
Prof. Dr. M. Scarpa, “Brains for Brain”-Foundation
Dr. J. Bowis, President of Health First Europe, Vice-President of the European Health Forum Gastein, Chairman of the Health Advisory Board of GlaxoSmithKline
Mr. M. Hadder, German Federation of Diabetics, Department NRW, Germany
Innovative PPPM-Centres: overall concept, medical imaging for disease prediction and prevention, innovative diagnostic tools, new perspectives in healthcare
Prof. Dr. G. P. Krestin, Erasmus MC, University Medical Centre Rotterdam, The Netherlands
Prof. Dr. G. Frija, ESR, Paris, France
Dr. V. Costigliola, General Practitioner, Brussels, Belgium
Dr. M. Kapalla, Faculty of Medicine, Comenius University, Bratislava, Slovakia; Negentropic Systems, s.r.o, Ruzomberok, Slovakia; National representative of EPMA in Slovakia
Dr. M. Pelsers, “Laboratory Stein GmbH”, Germany
Prof. Dr. O. Golubnitschaja, Radiologic Hospital, University of Bonn, Germany
Dr. K. Krapfenbauer, Medical University of Vienna, Austria; Vice-President of EPMA
Inflammation and Autoimmunity: Risk Assessment and Predictive Approaches through the Analytical Armamentarium
 Prof. Dr. S. Suchkov, The I.M. Sechenov First Moscow State Medical University, Russian Academy of Medical Sciences, Russia
Prof. Dr. A. Notkins, Scientific Director, NIDCR / NIH, Bethesda, USA
Prof. Dr. T. Marshall, Murdoch University of Western Australia
Tailored prevention: predictive, preventive and personalised concepts of traditional medicines, personalised nutrition, body culture & sport medicine
Prof. Dr. H. Boecker, University of Bonn, Germany
Dr. P. Roberti di Sarsina, Non-Conventional Medicine, High Council of Health, Ministry of Health, Italy
Prof. Dr. J. G. Ionescu, Specialised Clinic Neukirchen, Germany
Prof. Dr. G. Trovato, Catania University, Italy
Prof. Dr. K. Richter, University of Nurnberg, Germany; National Pepresentative of EPMA in Macedonia (FYROM) and Bavaria (Germany)
Prof. Dr. A. Kunin, The Voronezh N.N.Burdenko, State Medical Academy, Russia
Dr. R. Bubnov, Clinical hospital, State Affairs Department of Administration of the President of Ukraine, Kiev, Ukraine; National Representative of EPMA in Ukraine
Predictive Diagnostics and Personalised Medicine in Paediatrics
Prof. Dr. M. Scarpa, University of Padua, Italy, “Brains for Brain”-Foundation
Dr. J. Bowis, President of Health First Europe, Vice-President of the European Health Forum Gastein, Chairman of the Health Advisory Board of GlaxoSmithKline
Prof. Dr. D. Begley, King’s College London, UK
Prof. Dr. T. Cox, University of Cambridge, UK
Dr. G. Tsangaris, Proteomics Research Unit, Biomedical Research Foundation, Academy of Athens, Greece; National representative of EPMA In Greece
Prof. Dr. O. Golubnitschaja, University of Bonn, Germany
Predictive, Preventive and Personalised Medicine in Diabetes Care
Prof. Dr. M. Mozaffari, Georgia Health Sciences University, Augusta, Georgia, USA
Prof. Dr. L. Salminen, Ophthalmologic Clinic, University of Tampere, Finland, National Representative of EPMA in Finland
Prof. Dr. T. Josifova University Hospital Basel, Eye Clinic, Switzerland; National Representative of EPMA in Switzerland
Prof. Dr. J. Coelho, Department of Chemical Engineering, University of Coimbra, Portugal; National Representative of EPMA in Portugal
Dr. C. Sena, Medical Faculty, University of Coimbra, Portugal
Dr. W. Abebe, Georgia Health Sciences University, Augusta, Georgia, USA
Dr. R. Krishna, Department of Periodontics, College of Dental Medicine, Augusta, USA
M.Sc. M. Cebioglu, Molecular Diagnostics, Department of Radiology, University of Bonn, Germany
Prof. Dr. B. Baban, College of Dental Medicine, Georgia Health Sciences University, Augusta, Georgia, USA
Predictive, Preventive and Personalised Medicine in Cancer
Prof. Dr. D. Desiderio, University of Tennessee Health Science Center, Memphis, USA
Prof. Dr. D. Characiejus, Vilnius University, Lithuania; National Representative of EPMA in Lithuania
Prof. Dr. L. Berliner, Weill Cornell Medical College of Cornell University, New York, USA
Dr. S. Hagan, Glasgow Caledonian University, Scotland
Prof. Dr. R. Danesi, University of Pisa, Italy; National Representative of EPMA in Italy
 Dr. M. Mallmann, University of Bonn, Germany
Dr. Ch. Swanton, Translational Cancer Therapeutics Laboratory, London, UK
Dr. X. Zhan, University of Tennessee Health Science Center, Memphis, USA
Dr. A. González Neira, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; National Co-Representative of EPMA in Spain
Prof. Dr. Ch. Gerner, University of Vienna, Austria; National representative of EPMA in Austria
Prof. Dr. O. Topolcan, National Representative of EPMA in Czech Republic
Dr. S. Kovalenko, Deputy Director, Institute of Molecular biology and Biophysics, Novosibirsk, Russia
Prof. Dr. M. Pesta, Department of Internal Medicine, Faculty of Medicine in Pilsen, Charles University in Prague, Czech Republic
Prof. Dr. U. Rovigatti, Department of Oncology, University of Pisa Medical School, Pisa, Italy
Predictive, Preventive and Personalised Medicine in Neurodegenerative Diseases
Dr. S. Mandel, Technion, University of Haifa, Israel; Vice-President of EPMA
Prof. Dr. A. Tasker, University of British Columbia, Vancouver, Canada
Dr. A. Roses, Duke University and Zinfandel Pharmaceuticals, Inc., USA
Prof. Dr. Gabriel P. Krestin, Erasmus MC, University Medical Centre Rotterdam, The Netherlands
Dr. I. Grossman, Cabernet Pharmaceuticals, USA
Dr. O. Weinreb, Eve Topf Centers of Excellence for Neurodegenerative Diseases Research, Rappaport Family Research Institute, Israel
Prof. Dr. F. Paul, Charité Berlin, Germany; National Representative of EPMA in Germany
 Prof. Dr. L. Spiru, President "Ana ASLAN" International Foundation, Bucharest, Romania; National Representative of EPMA in Romania
Prof. Dr. D. Muresanu, President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN), Romania; National Co-epresentative of EPMA in Romania
Dr. K. Yeghiazaryan, Molecular Diagnostics, Department of Radiology, University of Bonn, Germany
Predictive, Preventive and Personalised Medicine in Cardiovascular Diseases
Prof. Dr. H. Iso, Osaka University, Japan; National Representative of EPMA in Japan
Prof. Dr. P. Evans, British Heart Foundation Cardiovascular Sciences Unit, National Heart and Lung Institute, Imperial College London, UK
Prof. Dr. J. Kastrup, The Heart Centre, Rigshospitalet University Hospital Copenhagen, Denmark; National Co-Representative of EPMA in Denmark
Prof. Dr. Ch. Gluud, Copenhagen University Hospital, Copenhagen, Denmark; Danish National Coordinator, ECRIN
Prof. Dr. H. Rosolova, Charles University in Prague, Medical Faculty in Pilsen, Czech Republic
Dr. F. de Meester, DMF-PL, Gliwice, Poland
Dr. H. Yatsuya, Nagoya University, Japan
Prof. Dr. J. Polivka, Chalrles University in Prague, Medical Faculty in Pilsen, Czech Republic
o Dr. Y. Kokubo, Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Suita, Japan
Dr. K. Yamagishi, Department of Public Health Medicine, University of Tsukuba, Tsukuba, Japan
Biomarker Discovery, Validation, Standardisation and practical application in medical practice
Prof. Dr. M. Ferrari, Centre for Genomics, Bioinformatics, and Biostatistics, San Raffaele Scientific Institute, Milan, Italy
Dr. P. Jacon, EDMA Director General, Brussels, Belgium
Dr. K. Krapfenbauer, Medical University of Vienna, Austria; Vice-Presindet of EPMA
Prof. Dr. J. Kzhyshkowska, Mannheim University of Heidelberg, Germany; National Representative of EPMA in Baden Wuerttemberg (Germany)
Prof. W. Lieb, Institute for Community Medicine, Ernst Moritz Arndt University Greifswald, Germany
Dr. Th. Joos, NMI Natural and Medical Sciences Institute at the University of Tübingen, Germany
Dr. P. Schulz-Knappe, Protagen AG, Dortmund, Germany
Dr. J. Walkenhorst, PROvendis, Germany
Dr. E. Moiseeva, Institute of Bioorganic Chemistry, Moscow, Russia
Dr. G. Grech, Faculty of Medicine and Surgery, University of Malta Medical School, Department of Pathology, Malta
Dr. M. Pilugina, Department of Medical Genetics and Clinical Neurophysiology of Postgraduate Education Institute, Krasnoyarsk State Medical University named after Prof. V.F. Vojno-Yasenetsky, Krasnoyarsk, Russian Federation
Patient-specific Modelling, Bioinformatics
Prof. Dr. H. Lemke, Computer Assisted Radiology and Surgery, CARS
Dr. M. Kapalla, Faculty of Medicine, Comenius University, Bratislava, Slovakia; Negentropic Systems, s.r.o, Ruzomberok, Slovakia; National Representative of EPMA in Slovakia
Prof. Dr. H. Podbielska, Wroclaw University, Poland; National Representative of EPMA in Poland
Prof. Dr. L. Berliner, Weill Cornell Medical College of Cornell University, New York, USA
Dr. A. Shabo, IBM Research Lab in Haifa, Israel
Dr. M. Marcus-Kalish, Interdisciplinary Center for Technology Analysis and Forecasting, Tel Aviv University, Israel
Bio-Banking, Ethics
Prof. Dr. R. Hewitt, European, Middle Eastern and African Society for Biopreservation and Biobanking, France
Prof. Dr. H. Everaus, Tartu University Hospital, Tartu, Estonia; National Representative of EPMA in Estonia
Prof. Dr. P. Riegman, Erasmus MC Tissue Bank, Erasmus MC Rotterdam, The Netherlands
Prof. Dr. Ch. Chabannon, Institut Paoli-Calmettes & Université d’Aix-Marseille, France
Prof. Dr. P. Hofman, Nice CHU Biobank, Pasteur Hospital, Nice, France
Dr. L. Leitsalu, Tartu University, Estonia
|
